Ronald B. Moss

940 citations

39 papers · 729 indexed · h-index 15

Co-authors: Dennis J. Carlo Mark R. Wallace Fred C. Jensen Fang Fang Wieslawa Giermakowska Roy T. Steigbigel Richard T. Davey Steven P. Richieri
Topics: HIV Research and Treatment (27 papers)Immune Cell Function and Interaction (16 papers)HIV/AIDS drug development and treatment (12 papers)
Cited by: Virology Immunology Infectious Diseases
Journals: Proceedings of the National Academy of Sciences PLoS ONE The Journal of Infectious Diseases
Partner nations: United States Canada Thailand

In The Last Decade

Ronald B. Moss

39 papers receiving 691 citations

Peers

Countries citing papers authored by Ronald B. Moss

Since Specialization

Citations

This map shows the geographic impact of Ronald B. Moss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald B. Moss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald B. Moss more than expected).

Fields of papers citing papers by Ronald B. Moss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald B. Moss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald B. Moss. The network helps show where Ronald B. Moss may publish in the future.

Co-authorship network of co-authors of Ronald B. Moss

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald B. Moss. A scholar is included among the top collaborators of Ronald B. Moss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald B. Moss. Ronald B. Moss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Brief Report: Higher Fentanyl Exposures Require Higher Doses of Naloxone for Successful Reversals in a Quantitative Systems Pharmacology Model 2022 ·Ronald B. Moss,(unknown),Rebecca Baillie,(unknown),(unknown),Malcolm Reed,Dennis J. Carlo	1
2	Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level 2020 ·PLoS ONE ·Ronald B. Moss,(unknown),Rebecca Baillie,(unknown),(unknown),(unknown),Dennis J. Carlo	31
3	Higher doses of naloxone are needed in the synthetic opioid era 2019 ·Substance Abuse Treatment Prevention and Policy ·Ronald B. Moss,Dennis J. Carlo	110
4	Comparative Pharmacokinetic Analysis of Community Use Naloxone formulations for Acute Treatment of Opioid Overdose 2019 ·Ronald B. Moss,(unknown),Charles P. Lollo,Dennis J. Carlo	2
5	Human factors study in untrained adolescents comparing a recently approved single-dose epinephrine prefilled syringe with an approved autoinjector 2018 ·Annals of Allergy Asthma & Immunology ·Ronald B. Moss,(unknown),Thomas Moll,Dennis J. Carlo	4
6	Targeting pandemic influenza: a primer on influenza antivirals and drug resistance 2010 ·Journal of Antimicrobial Chemotherapy ·Ronald B. Moss,Richard T. Davey,Roy T. Steigbigel,Fang Fang	55
7	Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein 2009 ·PLoS ONE ·Gallen Triana‐Baltzer,Larisa V. Gubareva,Alexander Klimov,(unknown),Ronald B. Moss,Maria Hedlund,Jeffrey L. Larson,Robert B. Belshe,Fang Fang	62
8	HIV-specific immunity during structured antiviral drug treatment interruption 2003 ·Vaccine ·Ronald B. Moss,Carolyn Brandt,Wieslawa Giermakowska,(unknown),Georgia Theofan,Maurizio Zanetti,Dennis J. Carlo,Mark R. Wallace	14
9	Propofol Phosphate, a Water-Soluble Propofol Prodrug:In Vivo Evaluation 2002 ·Anesthesia & Analgesia ·Mariusz Banaszczyk,(unknown),(unknown),Adam C. Lindsey,Ronald B. Moss,Dennis J. Carlo,Sheldon S. Hendler	38
10	HIV-Specific CD4 ⁺ and CD8 ⁺ Immune Responses Are Generated with a gp120-Depleted, Whole-Killed HIV-1 Immunogen with CpG Immunostimulatory Sequences of DNA 2000 ·Journal of Interferon & Cytokine Research ·Ronald B. Moss,Jocelyn P. Diveley,Fred C. Jensen,(unknown),(unknown),Dennis J. Carlo	15
11	Enhancement of HIV Type 1 Antigen-Specific CD4 ⁺ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen 2000 ·AIDS Research and Human Retroviruses ·Vernon C. Maino,Maria Suni,Susan B. Wormsley,Dennis J. Carlo,Mark R. Wallace,Ronald B. Moss	37
12	Insights into HIV-Specific Immune Function: Implications for Therapy and Prevention in the New Millennium 2000 ·Clinical Immunology ·Ronald B. Moss,Fred C. Jensen,Dennis J. Carlo	4
13	Enhancement of HIV Type 1 Antigen-Specific CD4 ⁺ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen 2000 ·AIDS Research and Human Retroviruses ·Vernon C. Maino,Maria Suni,Susan B. Wormsley,Dennis J. Carlo,Mark R. Wallace,Ronald B. Moss	8
14	Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogen 1999 ·AIDS ·Bruce K. Patterson,Dennis J. Carlo,Mark H. Kaplan,(unknown),(unknown),Ronald B. Moss	19
15	Phenotypic Analysis of Human Immunodeficiency Virus (HIV) Type 1 Cell‐Mediated Immune Responses after Treatment with an HIV‐1 Immunogen 1999 ·The Journal of Infectious Diseases ·Ronald B. Moss,Mark R. Wallace,Wieslawa Giermakowska,(unknown),(unknown),(unknown),Georgia Theofan,Roy Musil,Steven P. Richieri,Fred C. Jensen,Dennis J. Carlo	25
16	Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in Thailand 1998 ·AIDS ·Vina Churdboonchart,Ronald B. Moss,Worachart Sirawaraporn,(unknown),(unknown),Fred C. Jensen,(unknown),(unknown),Georgia Theofan,Dennis J. Carlo	12
17	Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccination 1998 ·Vaccine ·Paola Lanza,Ronald B. Moss,Wieslawa Giermakowska,(unknown),Steven P. Richieri,(unknown),Fred C. Jensen,(unknown),Dennis J. Carlo	4
18	Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 Infection 1997 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Ronald B. Moss,Richard Trauger,Wieslawa Giermakowska,John L. Turner,Mark R. Wallace,Fred C. Jensen,Steven P. Richieri,F. Ferré,Anne E. Daigle,(unknown),Georgia Theofan,Dennis J. Carlo	27
19	HIV-1-Specific Functional ImmuneMeasurements as Markers ofDisease Progression 1997 ·Journal of Biomedical Science ·Ronald B. Moss,Steven P. Richieri,F. Ferré,Anne E. Daigle,Richard Trauger,Georgia Theofan,Wieslawa Giermakowska,Paola Lanza,Steven W. Brostoff,Dennis J. Carlo,Fred C. Jensen	1
20	Early Clinical Markers and CD4 Percentage in Subjects with Human Immunodeficiency Virus Infection 1996 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Mark R. Wallace,Ronald B. Moss,H. James Beecham,(unknown),(unknown),(unknown),Robert L. Murphy,David H. Shepp,Frederick P. Siegal,John L. Turner,Sharon Safrin,Dennis J. Carlo,Alexandra M. Levine	5

About Ronald B. Moss

Ronald B. Moss is a scholar working on Virology, Infectious Diseases and Immunology, having authored 39 papers that have together received 729 indexed citations. Recurring topics across this work include HIV Research and Treatment (27 papers), Immune Cell Function and Interaction (16 papers) and HIV/AIDS drug development and treatment (12 papers). The work is most often cited by research in Virology (360 citations), Immunology (258 citations) and Infectious Diseases (219 citations). Ronald B. Moss has collaborated with scholars based in United States, Canada and Thailand. Frequent co-authors include Dennis J. Carlo, Mark R. Wallace, Fred C. Jensen, Fang Fang, Wieslawa Giermakowska, Roy T. Steigbigel, Richard T. Davey, Steven P. Richieri, Georgia Theofan and Alfredo Garzino‐Demo. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact